FBK:MILFinecoBank SpA Analysis
Data as of 2026-06-13 - not real-time
€21.93
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: FinecoBank trades at €21.93, comfortably above its 20‑day (≈20.99) and 50‑day (≈21.12) SMAs and just below the immediate resistance of €22.15, with a solid support at €20.18. The RSI sits at 61, indicating momentum is still healthy but not overbought, while the MACD line is bullish (0.099 above the signal at 0.012). Volume has been tapering, yet the 30‑day volatility of roughly 26% and a low beta of 0.47 suggest price swings are manageable and the stock is less correlated with broader market moves.
Fundamental backdrop: Revenue grew 4% YoY to €343 m and the bank boasts an exceptional operating margin of 71% and profit margin of 48%, translating into a ROE of 24.6%. With €2.33 bn of cash and modest debt (€0.84 bn), the balance sheet is strong and the dividend yield of 3.6% (payout ~70%) appears sustainable. However, a forward PE of 18.1 and a price‑to‑book of 5x sit above the industry averages (PE ≈16.8), implying the stock is priced at a premium. Analysts project a 14.8% upside, and the consensus “strong buy” rating aligns with the attractive dividend and steady earnings growth.
Fundamental backdrop: Revenue grew 4% YoY to €343 m and the bank boasts an exceptional operating margin of 71% and profit margin of 48%, translating into a ROE of 24.6%. With €2.33 bn of cash and modest debt (€0.84 bn), the balance sheet is strong and the dividend yield of 3.6% (payout ~70%) appears sustainable. However, a forward PE of 18.1 and a price‑to‑book of 5x sit above the industry averages (PE ≈16.8), implying the stock is priced at a premium. Analysts project a 14.8% upside, and the consensus “strong buy” rating aligns with the attractive dividend and steady earnings growth.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and healthy RSI
- Attractive 3.6% dividend yield
- Price near support with upside potential
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong operating margins and ROE
- Robust cash position and low leverage
- Analyst consensus target implying ~15% upside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend and cash generation
- Modest revenue growth and premium valuation
- Potential regulatory headwinds in the regional banking sector
Key Metrics & Analysis
Financial Health
Revenue Growth4.20%
Profit Margin48.74%
P/E Ratio20.7
ROE24.60%
ROA1.80%
P/B Ratio5.0
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI61.4
Support€20.18
Resistance€22.15
MA 20€20.99
MA 50€21.12
MA 200€20.40
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target Price€25.18
Upside/Downside14.80%
GradeOvervalued
TypeBlend
Dividend Yield3.60%
Risk Assessment
Beta0.47
Volatility26.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.